Davita Healthcare Partners Inc (DVA) Stock Price, Quote & News

Company Profile

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administ...

Industry: Medical Care Facilities

Sector: Healthcare

Phone: 720 631 2100

Website: www.davita.com

Address:

2000 16th Street, Denver, United States

CosmicMiner Jun. 23 at 9:51 PM

$DVA is on a tear, surging +84.2% YTD. Capital allocation remains aggressive as the company repurchased $402.9M of shares in Q1 at an average price of $133.70. Solid management execution and strong fundamental tailwinds driving the macro breakout.

0 · Reply

Noname2022 Jun. 23 at 5:20 PM

$CRMD $AKBA $DVA $FMS For those following K-CAPA advocacy

2 · Reply

FibonacciTrader_ Jun. 22 at 11:59 PM

All of these stocks are making new ALL-TIME highs today Momentum is clearly not slowing down. $TXN - analog strength + stable cash flow engine re-rating higher $LRCX - +2% | wafer fab equipment demand tied directly to AI chip scaling $ADI - +2% | precision analog leadership in industrial + AI power systems $DVA - +2% | defensive healthcare strength quietly breaking higher $AMD - +2% | AI compute narrative re-igniting momentum in high-beta semis New highs are not random - they’re capital confirming where future earnings visibility is strongest. Weak hands fade here. Trend followers stay with it

0 · Reply

Noname2022 Jun. 22 at 10:32 PM

$CRMD $AKBA $FMS $DVA When does the CY2027 ESRD PPS proposed rule finally drop? Key watch item for post-TDAPA math.

2 · Reply

Gencooliveoil Jun. 22 at 8:30 PM

$AKBA $CRMD $DVA $FMS

0 · Reply

capitalthinktank Jun. 22 at 7:54 PM

Every name here is hitting new all-time highs today. $KLAC +3% $TXN +2% $LRCX +2% $ADI +2% $DVA +2% AMD +2% What’s notable here is the breadth inside the chip ecosystem. It’s not just leading-edge GPUs - it’s equipment, analog, and memory-adjacent names all participating. That usually signals the entire semiconductor cycle is being repriced, not just one segment. Next alert dropping soon. If notifications are off, you’ll likely see it after the move is already done.

0 · Reply

Noname2022 Jun. 22 at 4:18 PM

$AKBA $CRMD $DVA $FMS For those following K-CAPA

1 · Reply

Gencooliveoil Jun. 22 at 11:10 AM

$CRMD $FMS $DVA

0 · Reply

Noname2022 Jun. 21 at 6:13 PM

$DVA $FMS $CRMD $AKBA Support K-CAPA / S.2730 / H.R.6214. Takes 30 seconds and sends a message to your senators and representative. Please take a moment and don’t forget to submit on the second page. https://kidneyaction.org/support-s-2730-hr-6214-the-kidney-care-access-protection-act/

3 · Reply

Noname2022 Jun. 21 at 6:04 PM

$CRMD $FMS $DVA Reminder: An MDO (likely IRC) reduced CBSRI’s by 97% with Defencath! https://www.dpcedcenter.org/wp-content/uploads/2026/06/KIDNEY-CITIZEN-23-Digital.pdf

0 · Reply

DaVita Sets Bold 2030 Community Care Commitments After Exceeding Prior Five-Year ESG Goals

May 12, 2026, 5:20 PM EDT - 6 weeks ago

DaVita Transcript: Bank of America Global Healthcare Conference 2026

2026-05-11T14:28:21.000Z - 6 weeks ago

DaVita price target raised to $201 from $144 at TD Cowen

2026-05-08T11:57:34.000Z - 6 weeks ago

DaVita price target raised to $205 from $158 at Truist

2026-05-07T13:29:05.000Z - 6 weeks ago

DaVita price target raised to $235 from $190 at UBS

2026-05-07T11:44:30.000Z - 6 weeks ago

DaVita price target raised to $194 from $158 at Barclays

2026-05-07T10:41:29.000Z - 6 weeks ago

DaVita upgraded to Buy from Hold at Deutsche Bank

2026-05-07T03:38:03.000Z - 6 weeks ago

DaVita rises 19.6%

May 6, 2026, 6:01 PM EDT - 6 weeks ago

DaVita Inc. to Participate in the BofA Securities 2026 Health Care Conference

May 5, 2026, 5:31 PM EDT - 7 weeks ago

DaVita lifts annual profit forecast on strong demand for dialysis services

May 5, 2026, 5:00 PM EDT - 7 weeks ago

DaVita Earnings Call Transcript: Q1 2026

May 5, 2026, 5:00 PM EDT - 7 weeks ago

DaVita Earnings release: Q1 2026

May 5, 2026, 5:00 PM EDT - 7 weeks ago

DaVita Quarterly report: Q1 2026

2026-05-05T20:28:38.000Z - 7 weeks ago

DaVita reports Q1 EPS $2.87, consensus $2.33

2026-05-05T20:23:26.000Z - 7 weeks ago

DaVita sees FY26 adjusted EPS $14.10-$15.20, consensus $14.12

May 5, 2026, 4:05 PM EDT - 7 weeks ago

DaVita Inc. 1st Quarter 2026 Results

Apr 28, 2026, 7:00 AM EDT - 2 months ago

Honeywell Announces Board of Directors for Honeywell Aerospace

HON

Apr 22, 2026, 8:00 AM EDT - 2 months ago

DaVita Proxy statement: Proxy filing

Apr 22, 2026, 8:00 AM EDT - 2 months ago

DaVita Proxy statement: Proxy filing

Apr 20, 2026, 2:06 PM EDT - 2 months ago

DaVita Inc. Schedules 1st Quarter 2026 Investor Conference Call

Mar 18, 2026, 3:00 PM EDT - 3 months ago

DaVita Highlights Continued Progress in Value-Based Kidney Care as CKCC Results Show Year-Over-Year Improvement

Mar 17, 2026, 7:00 AM EDT - 3 months ago

R1 Therapeutics launches with oversubscribed $77.5 million Series A financing to advance first-in-class treatment for hyperphosphatemia in patients with chronic kidney disease

Mar 2, 2026, 11:50 AM EST - 4 months ago

DaVita Transcript: TD Cowen 46th Annual Health Care Conference

Feb 24, 2026, 2:00 PM EST - 4 months ago

DaVita Inc. to Participate in TD Cowen's 46th Annual Health Care Conference

Feb 11, 2026, 10:45 AM EST - 4 months ago

20 stocks of companies that delivered a double dose of growth this earnings season

APH BA CAH FICO GLW GOOG GOOGL

2026-02-05T15:05:21.000Z - 4 months ago

DaVita price target raised to $158 from $128 at Truist

2026-02-04T13:50:41.000Z - 4 months ago

DaVita price target raised to $144 from $133 at TD Cowen

2026-02-04T11:36:08.000Z - 4 months ago

DaVita price target raised to $190 from $186 at UBS

2026-02-03T19:11:46.000Z - 5 months ago

DaVita Stock (DVA) Soars 20% as Financial Results Beat Wall Street Estimates

BRK.B

2026-02-03T17:05:35.000Z - 5 months ago

DaVita rises 21.7%

Feb 3, 2026, 11:00 AM EST - 5 months ago

TER Quarterly Sales Top $1B, DVA & PEP Beat Earnings

PEP TER

Feb 2, 2026, 5:06 PM EST - 5 months ago

DaVita forecasts 2026 profit above estimates on steady dialysis service demand; shares jump

Feb 2, 2026, 5:00 PM EST - 5 months ago

DaVita Earnings Call Transcript: Q4 2025

Feb 2, 2026, 5:00 PM EST - 5 months ago

DaVita Annual report: Q4 2025

Feb 2, 2026, 5:00 PM EST - 5 months ago

DaVita Earnings release: Q4 2025

Feb 2, 2026, 5:00 PM EST - 5 months ago

DaVita Annual report: Q4 2025

Feb 2, 2026, 4:05 PM EST - 5 months ago

DaVita Inc. 4th Quarter 2025 Results

Jan 21, 2026, 10:00 AM EST - 5 months ago

DaVita Inc. Schedules 4th Quarter 2025 Investor Conference Call

Dec 11, 2025, 8:00 AM EST - 6 months ago

DaVita Names New Leaders to Accelerate Care Transformation

Nov 17, 2025, 11:20 AM EST - 7 months ago

DaVita Transcript: Wolfe Research Healthcare Conference 2025

Nov 14, 2025, 4:16 PM EST - 7 months ago

DaVita Inc. to Participate in Fireside Chat with Wolfe Research

Nov 4, 2025, 8:00 AM EST - 8 months ago

DaVita Marks 25 Years of Innovation with Breakthrough Kidney Care Research at ASN Kidney Week 2025

Oct 29, 2025, 5:32 PM EDT - 8 months ago

DaVita misses quarterly profit estimates on rising costs, lower volumes

Oct 29, 2025, 5:00 PM EDT - 8 months ago

DaVita Earnings Call Transcript: Q3 2025

Oct 29, 2025, 5:00 PM EDT - 8 months ago

DaVita Quarterly report: Q3 2025

Oct 29, 2025, 5:00 PM EDT - 8 months ago

DaVita Earnings release: Q3 2025

Oct 29, 2025, 4:05 PM EDT - 8 months ago

DaVita Inc. 3rd Quarter 2025 Results

Oct 20, 2025, 8:00 AM EDT - 8 months ago

DaVita Leads the Way in Evaluating Middle Molecule Clearance with Two New Initiatives

Oct 13, 2025, 2:00 PM EDT - 9 months ago

DaVita Inc. Schedules 3rd Quarter 2025 Investor Conference Call

Aug 27, 2025, 8:00 AM EDT - 10 months ago

DaVita Honors 25 Years of Clinical Advancement in Chronic Disease Care

Aug 21, 2025, 5:59 PM EDT - 10 months ago

Ransomware attack at dialysis firm DaVita affects 2.7 million people, US health dept website shows

Aug 5, 2025, 5:15 PM EDT - 11 months ago

DaVita beats quarterly profit on steady demand for dialysis services

Aug 5, 2025, 5:00 PM EDT - 11 months ago

DaVita Earnings Call Transcript: Q2 2025

Aug 5, 2025, 5:00 PM EDT - 11 months ago

DaVita Quarterly report: Q2 2025

Aug 5, 2025, 5:00 PM EDT - 11 months ago

DaVita Earnings release: Q2 2025

Aug 5, 2025, 4:05 PM EDT - 11 months ago

DaVita Inc. 2nd Quarter 2025 Results

Jul 17, 2025, 5:37 PM EDT - 1 year ago

DaVita Inc. Schedules 2nd Quarter 2025 Investor Conference Call

Jun 2, 2025, 12:15 PM EDT - 1 year ago

20 stocks primed for rapid growth while trading at half of Nvidia's valuation

AIG APTV BALL CTRA DELL ELV EQT

May 30, 2025, 2:35 PM EDT - 1 year ago

DaVita Statement on Government's Kidney Care Choices (KCC) Model Updates

May 20, 2025, 4:42 PM EDT - 1 year ago

DaVita Inc. Announces Upsize and Pricing of $1 Billion Senior Notes Offering

May 20, 2025, 9:05 AM EDT - 1 year ago

DaVita Releases Annual Community Care Report, Highlights Achievements in Corporate Citizenship

May 20, 2025, 8:51 AM EDT - 1 year ago

DaVita Inc. Announces Offering of $750 Million Senior Notes

May 12, 2025, 5:37 PM EDT - 1 year ago

DaVita beats quarterly profit estimates amid stable demand for dialysis services

May 12, 2025, 5:00 PM EDT - 1 year ago

DaVita Earnings Call Transcript: Q1 2025

May 12, 2025, 5:00 PM EDT - 1 year ago

DaVita Quarterly report: Q1 2025

May 12, 2025, 5:00 PM EDT - 1 year ago

DaVita Earnings release: Q1 2025

May 12, 2025, 4:51 PM EDT - 1 year ago

DaVita First-Quarter 2025 Financial Results: Just the Numbers

May 12, 2025, 4:05 PM EDT - 1 year ago

DaVita Inc. 1st Quarter 2025 Results

Apr 30, 2025, 11:00 AM EDT - 1 year ago

DaVita Inc. Schedules 1st Quarter 2025 Investor Conference Call

Apr 24, 2025, 8:00 AM EDT - 1 year ago

DaVita Proxy statement: Proxy Filing

Apr 24, 2025, 8:00 AM EDT - 1 year ago

DaVita Proxy statement: Proxy Filing

Apr 14, 2025, 7:35 AM EDT - 1 year ago

DaVita Says Ransomware Attack Affecting Some Operations

Apr 14, 2025, 7:33 AM EDT - 1 year ago

Dialysis firm DaVita hit by ransomware attack

Mar 31, 2025, 7:35 AM EDT - 1 year ago

These 15 stocks are the most profitable companies in the S&P 500

AAPL ABBV AON BA CL CLX COR

Mar 11, 2025, 9:00 AM EDT - 1 year ago

DaVita Transcript: Barclays 27th Annual Global Healthcare Conference

Mar 6, 2025, 10:00 AM EST - 1 year ago

DaVita Inc. to Participate in the Barclays Global Healthcare Conference 2025

Feb 27, 2025, 9:00 AM EST - 1 year ago

YMCA of the USA Deepens Collaboration with DaVita to Drive Kidney Health Initiatives in Seven Communities

Feb 19, 2025, 8:05 PM EST - 1 year ago

Berkshire Hathaway sells another 750,000 DaVita shares

Feb 14, 2025, 1:01 PM EST - 1 year ago

DaVita's stock leads S&P 500 decliners after Berkshire pares stake. Its soft guidance isn't helping.

Feb 14, 2025, 8:16 AM EST - 1 year ago

Warren Buffett's Berkshire Hathaway sells some DaVita; Shares fall on disappointing guidance

Feb 13, 2025, 8:13 PM EST - 1 year ago

Berkshire sells some DaVita shares, cuts stake to 45%

Feb 13, 2025, 6:07 PM EST - 1 year ago

DaVita forecasts 2025 profit below estimates, shares plummet

Feb 13, 2025, 5:00 PM EST - 1 year ago

DaVita Earnings Call Transcript: Q4 2024

Feb 13, 2025, 5:00 PM EST - 1 year ago

DaVita Annual report: Q4 2024

Feb 13, 2025, 5:00 PM EST - 1 year ago

DaVita Earnings release: Q4 2024

Feb 13, 2025, 4:05 PM EST - 1 year ago

DaVita Inc. 4th Quarter 2024 Results

Jan 30, 2025, 11:55 AM EST - 1 year ago

DaVita Inc. Schedules 4th Quarter 2024 Investor Conference Call

Jan 28, 2025, 2:39 PM EST - 1 year ago

Barclays' Andrew Mok: Any sustained underperformance in big tech will likely benefit healthcare

CI CVS HCA UHS

Jan 15, 2025, 9:05 AM EST - 1 year ago

DaVita Celebrates 25 Years of Exceptional Patient Care, Empowering the Future of Kidney Health

Jan 9, 2025, 11:00 AM EST - 1 year ago

DaVita Supports Thousands of Patients and Teammates Affected by Southern California Wildfires

CosmicMiner Jun. 23 at 9:51 PM

0 · Reply

Noname2022 Jun. 23 at 5:20 PM

$CRMD $AKBA $DVA $FMS For those following K-CAPA advocacy

2 · Reply

FibonacciTrader_ Jun. 22 at 11:59 PM

0 · Reply

Noname2022 Jun. 22 at 10:32 PM

$CRMD $AKBA $FMS $DVA When does the CY2027 ESRD PPS proposed rule finally drop? Key watch item for post-TDAPA math.

2 · Reply

Gencooliveoil Jun. 22 at 8:30 PM

$AKBA $CRMD $DVA $FMS

0 · Reply

capitalthinktank Jun. 22 at 7:54 PM

0 · Reply

Noname2022 Jun. 22 at 4:18 PM

$AKBA $CRMD $DVA $FMS For those following K-CAPA

1 · Reply

Gencooliveoil Jun. 22 at 11:10 AM

$CRMD $FMS $DVA

0 · Reply

Noname2022 Jun. 21 at 6:13 PM

3 · Reply

Noname2022 Jun. 21 at 6:04 PM

$CRMD $FMS $DVA Reminder: An MDO (likely IRC) reduced CBSRI’s by 97% with Defencath! https://www.dpcedcenter.org/wp-content/uploads/2026/06/KIDNEY-CITIZEN-23-Digital.pdf

0 · Reply

Noname2022 Jun. 20 at 12:20 AM

$AKBA $DVA Gosh! Why are DaVita doctors such idiots? They could just prescribe Vafseo faster and make the stock go up. Freakin’ idiots.

2 · Reply

Noname2022 Jun. 18 at 7:27 PM

$CRMD $DVA $AKBA $FMS For those following K-CAPA policy advocacy

3 · Reply

WallStJesus Jun. 17 at 11:27 PM

$DVA -

0 · Reply

Noname2022 Jun. 17 at 6:18 PM

$CRMD $DVA $AKBA $FMS For those following K-CAPA policy / advocacy

2 · Reply

peloswing Jun. 17 at 6:14 PM

$DVA trading at fresh all-time highs today and seeing nice bullish net flow divergence today. The 3 most popular contracts today are: - 6/18 $200 calls🟢 - 1/15 $230 calls🟢 - 12/18 $210 calls 🟢

0 · Reply

SwingTraderPro1 Jun. 17 at 2:38 PM

PREMARKET MOVERS - JUNE 17 BIGGEST LOSERS • $NSC -6% - notable large-cap under pressure in early trading • $MRSH -5% - insurance / professional services sector weakness showing through premarket • $AMP -5% - financials leading downside with risk-off tone in the group • $DVA -4% -healthcare services soft as defensive rotation fades intraday • $POOL -4% - housing / consumer discretionary exposure under pressure Overall tone: selective premarket selling concentrated in financials, healthcare services, and cyclicals - more rotation pressure than broad systemic risk at this stage.

0 · Reply

Noname2022 Jun. 16 at 7:13 PM

$AKBA $DVA $CRMD $FMS For those following K-CAPA policy / advocacy

1 · Reply

AdamBrennan2 Jun. 16 at 2:26 PM

$AMN came up on my Reversed DCF screener as pricing in most FCF decline.. potentially lots of value here.. $LH $GH $BTSG $DVA

0 · Reply

Tiger10 Jun. 16 at 1:05 PM

$AKBA $DVA you’re running out of material brother

0 · Reply

Noname2022 Jun. 16 at 12:59 PM

$AKBA $DVA Gosh! Why are DaVita doctors such idiots? They could just prescribe Vafseo faster and make the stock go up. Freakin’ idiots.

1 · Reply

Noname2022 Jun. 15 at 8:47 PM

$CRMD $DVA $AKBA $FMS For those following K-CAPA advocacy

1 · Reply

Noname2022 Jun. 14 at 12:46 AM

$AKBA $DVA Gosh! Why are DaVita doctors such idiots? They could just prescribe Vafseo faster and make the stock go up. Freakin’ idiots.

1 · Reply

Market Cap	12.77B
Revenue (ttm)	13.64B
Net Income (ttm)	746.80M
EPS (ttm)	N/A
PE Ratio	16.94
Forward PE	13.18
Profit Margin	5.47%
Debt to Equity Ratio	-22.49

Volume	586,295
Avg Vol	879,160
Day's Range	N/A - N/A
Shares Out	64.20M
Stochastic %K	96%
Beta	0.84
Analysts	Sell
Price Target	$190.50